Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
U.S.
No access to market insights

In the U.S., women, especially in the age group of 19 to 50 years, are increasingly becoming health conscious owing to the growing incidence of chronic diseases, which is also one of the significant factors boosting the adoption of women’s health therapeutics in the country.

The increase in the population of women aged 65 and above is leading to a rise in the prevalence of medical conditions associated with aging such as osteoporosis and menopause. By 2050, the population of women aged 65 and above is expected to increase by 81%.

Moreover, increase in the number of women suffering from osteoporosis, obesity, depression, & menstrual disorders and high awareness in the target population are among the factors driving the market.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Scope

Women's health market segmentation & scope
Application
Hormonal Infertility
Contraceptives
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Polycystic Ovary Syndrome (PCOS)
Drug Class
Hormonal Therapies
Bone Health Agents
Fertility Agents
GnRH Modulators
Pain and Symptom Management
Metabolic Agents
Others
Age
50 years and above
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Others
Others

Women's Health Market Companies

Name Profile # Employees HQ Website

U.S. women's health market

U.S. Women's Health Market Outlook Share, 2024 & 2030 (US$M)

U.S. women's health market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more